SGLT2 inhibitor use in the management of feline diabetes mellitus
- PMID: 38954371
- PMCID: PMC11736986
- DOI: 10.1111/jvp.13466
SGLT2 inhibitor use in the management of feline diabetes mellitus
Abstract
Sodium-glucose cotransporter-2 (SGLT2) inhibitors are routinely used in the management of human type 2 diabetes and have been shown to effectively mitigate hyperglycemia and reduce the risks of cardiovascular and renal compromise. Two SGLT2 inhibitors, namely bexagliflozin and velagliflozin, were recently FDA approved for the treatment of uncomplicated feline diabetes mellitus. These oral hypoglycemic agents are a suitable option for many newly diagnosed cats, with rapid improvements in glycemic control and clinical signs. Suitable candidates must have some residual β-cell function, as some endogenous insulin production is required to prevent ketosis. Appropriate patient selection and monitoring are necessary, and practitioners should be aware of serious complications such as euglycemic diabetic ketoacidosis.
Keywords: bexagliflozin; cat; diabetes; velagliflozin.
© 2024 The Author(s). Journal of Veterinary Pharmacology and Therapeutics published by John Wiley & Sons Ltd.
Conflict of interest statement
Dr. Audrey Cook and Dr. Ellen Behrend are paid consultants for Boehringer Ingelheim. Dr. Audrey Cook is a paid consultant for Elanco Animal Health.
References
-
- American Diabetes Association American Diabetes Association: Diabetes and Statistics. https://diabetes.org/about‐diabetes/statistics
-
- Avgerinos, I. , Karagiannis, T. , Kakotrichi, P. , Michailidis, T. , Liakos, A. , Matthews, D. R. , Tsapas, A. , & Bekiari, E. (2022). Sotagliflozin for patients with type 2 diabetes: A systematic review and meta‐analysis. Diabetes, Obesity & Metabolism, 24(1), 106–114. - PubMed
-
- Bailiff, N. L. , Nelson, R. W. , Feldman, E. C. , Westropp, J. L. , Ling, G. V. , Jang, S. S. , & Kass, P. H. (2006). Frequency and risk factors for urinary tract infection in cats with diabetes mellitus. Journal of Veterinary Internal Medicine, 20(4), 850–855. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
